Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
Revolutionary technology will further boost OneSource’s scientific services offerings
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
The facility is a part of Lupin Manufacturing Solutions
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
Subscribe To Our Newsletter & Stay Updated
